{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T22:47:34Z","timestamp":1791240454041,"version":"4.1.0"},"reference-count":108,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000738","name":"Department of Veterans Affairs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009560","name":"American Gastroenterological Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009560","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastrointestinal Endoscopy Clinics of North America"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.giec.2021.03.006","type":"journal-article","created":{"date-parts":[[2021,5,27]],"date-time":"2021-05-27T06:39:56Z","timestamp":1622097596000},"page":"519-542","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Chemoprevention Against Gastric Cancer"],"prefix":"10.1016","volume":"31","author":[{"given":"Shailja C.","family":"Shah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Richard M.","family":"Peek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.giec.2021.03.006_bib1","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.giec.2021.03.006_bib2","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1093\/jnci\/djx262","article-title":"The Changing Face of Noncardia Gastric Cancer Incidence Among US Non-Hispanic Whites","volume":"110","author":"Anderson","year":"2018","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.giec.2021.03.006_bib3","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/ajg.2009.728","article-title":"Pathology of gastric intestinal metaplasia: clinical implications","volume":"105","author":"Correa","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.giec.2021.03.006_bib4","first-page":"59","article-title":"Helicobacter pylori infection and gastric adenocarcinoma","volume":"7","author":"Correa","year":"2011","journal-title":"US Gastroenterol Hepatol Rev"},{"key":"10.1016\/j.giec.2021.03.006_bib5","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1056\/NEJM199110173251604","article-title":"Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii","volume":"325","author":"Nomura","year":"1991","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.giec.2021.03.006_bib6","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1056\/NEJM199110173251603","article-title":"Helicobacter pylori infection and the risk of gastric carcinoma","volume":"325","author":"Parsonnet","year":"1991","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.giec.2021.03.006_bib7","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1136\/bmj.302.6788.1302","article-title":"Association between infection with Helicobacter pylori and risk of gastric cancer: evidence from a prospective investigation","volume":"302","author":"Forman","year":"1991","journal-title":"BMJ"},{"key":"10.1016\/j.giec.2021.03.006_bib8","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1136\/gut.49.3.347","article-title":"Gastric cancer and Helicobacter pylori: a combined analysis of 12 case control studies nested within prospective cohorts","volume":"49","year":"2001","journal-title":"Gut"},{"key":"10.1016\/j.giec.2021.03.006_bib9","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1056\/NEJMcp1001110","article-title":"Clinical practice. Helicobacter pylori infection","volume":"362","author":"McColl","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.giec.2021.03.006_bib10","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1053\/j.gastro.2017.04.022","article-title":"Global Prevalence of Helicobacter pylori Infection: systematic Review and Meta-Analysis","volume":"153","author":"Hooi","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.giec.2021.03.006_bib11","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1002\/ijc.28999","article-title":"Global burden of gastric cancer attributable to Helicobacter pylori","volume":"136","author":"Plummer","year":"2015","journal-title":"Int J Cancer"},{"key":"10.1016\/j.giec.2021.03.006_bib12","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1111\/j.1349-7006.2002.tb01209.x","article-title":"Synergistic promoting effects of Helicobacter pylori infection and high-salt diet on gastric carcinogenesis in Mongolian gerbils","volume":"93","author":"Nozaki","year":"2002","journal-title":"Jpn J Cancer Res"},{"key":"10.1016\/j.giec.2021.03.006_bib13","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1002\/ijc.23245","article-title":"4-Vinyl-2,6-dimethoxyphenol (canolol) suppresses oxidative stress and gastric carcinogenesis in Helicobacter pylori-infected carcinogen-treated Mongolian gerbils","volume":"122","author":"Cao","year":"2008","journal-title":"Int J Cancer"},{"key":"10.1016\/j.giec.2021.03.006_bib14","doi-asserted-by":"crossref","first-page":"e0120938","DOI":"10.1371\/journal.pone.0120938","article-title":"Canolol inhibits gastric tumors initiation and progression through COX-2\/PGE2 pathway in K19-C2mE transgenic mice","volume":"10","author":"Cao","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.giec.2021.03.006_bib15","first-page":"1273","article-title":"Unidentified curved bacilli on gastric epithelium in active chronic gastritis","volume":"1","author":"Warren","year":"1983","journal-title":"Lancet"},{"key":"10.1016\/j.giec.2021.03.006_bib16","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1016\/S0140-6736(95)91084-0","article-title":"Long-term sequelae of Helicobacter pylori gastritis","volume":"345","author":"Kuipers","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.giec.2021.03.006_bib17","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/dju352","article-title":"RE: Effects of helicobacter pylori treatment on gastric cancer incidence and mortality in subgroups","volume":"106","author":"Graham","year":"2014","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.giec.2021.03.006_bib18","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1136\/gut.2004.056549","article-title":"The time to eradicate gastric cancer is now","volume":"54","author":"Graham","year":"2005","journal-title":"Gut"},{"key":"10.1016\/j.giec.2021.03.006_bib19","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1056\/NEJMoa1909666","article-title":"Family history of gastric cancer and helicobacter pylori treatment","volume":"382","author":"Choi","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.giec.2021.03.006_bib20","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1056\/NEJMoa1708423","article-title":"Helicobacter pylori therapy for the prevention of metachronous gastric cancer","volume":"378","author":"Choi","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.giec.2021.03.006_bib21","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/apt.12402","article-title":"Randomised clinical trial: the effects of Helicobacter pylori eradication on glandular atrophy and intestinal metaplasia after subtotal gastrectomy for gastric cancer","volume":"38","author":"Cho","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.giec.2021.03.006_bib22","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1053\/j.gastro.2016.01.028","article-title":"Association between helicobacter pylori eradication and gastric cancer incidence: a systematic review and meta-analysis","volume":"150","author":"Lee","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.giec.2021.03.006_bib23","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1093\/jnci\/92.23.1881","article-title":"Chemoprevention of gastric dysplasia: randomized trial of antioxidant supplements and anti-helicobacter pylori therapy","volume":"92","author":"Correa","year":"2000","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.giec.2021.03.006_bib24","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1002\/ijc.25337","article-title":"Gastric cancers in Finnish patients after cure of Helicobacter pylori infection: a cohort study","volume":"128","author":"Kosunen","year":"2011","journal-title":"Int J Cancer"},{"key":"10.1016\/j.giec.2021.03.006_bib25","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1136\/gutjnl-2017-315363","article-title":"Helicobacter pylori eradication treatment and the risk of gastric adenocarcinoma in a Western population","volume":"67","author":"Doorakkers","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.giec.2021.03.006_bib26","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1053\/j.gastro.2019.10.019","article-title":"Risk factors and incidence of gastric cancer after detection of helicobacter pylori infection: a large cohort study","volume":"158","author":"Kumar","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.giec.2021.03.006_bib27","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1136\/gutjnl-2019-319000","article-title":"Reply to: Helicobacter pylori eradication treatment and the risk of gastric adenocarcinoma in a western population","volume":"69","author":"Doorakkers","year":"2020","journal-title":"Gut"},{"key":"10.1016\/j.giec.2021.03.006_bib28","article-title":"Practice update: risk factors and incidence of gastric cancer after detection of helicobacter pylori infection","author":"Shah","year":"2019","journal-title":"J\u00a0Scan Pract Update"},{"key":"10.1016\/j.giec.2021.03.006_bib29","first-page":"CD005583","article-title":"Helicobacter pylori eradication for the prevention of gastric neoplasia","volume":"7","author":"Ford","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.giec.2021.03.006_bib30","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1136\/gutjnl-2011-300154","article-title":"Effects of selective COX-2 inhibitor and Helicobacter pylori eradication on precancerous gastric lesions","volume":"61","author":"Wong","year":"2012","journal-title":"Gut"},{"key":"10.1016\/j.giec.2021.03.006_bib31","article-title":"Impact of H-pylori eradication on gastric cancer prevention: endoscopic results of the Japanese intervention trial (JITHP-study). A Randomized multi-center trial","author":"Saito","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.giec.2021.03.006_bib32","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1001\/jama.291.2.187","article-title":"Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial","volume":"291","author":"Wong","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.giec.2021.03.006_bib33","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1093\/jnci\/djj264","article-title":"Randomized double-blind factorial trial of three treatments to reduce the prevalence of precancerous gastric lesions","volume":"98","author":"You","year":"2006","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.giec.2021.03.006_bib34","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1136\/gut.2003.034629","article-title":"Factors predicting progression of gastric intestinal metaplasia: results of a randomised trial on Helicobacter pylori eradication","volume":"53","author":"Leung","year":"2004","journal-title":"Gut"},{"key":"10.1016\/j.giec.2021.03.006_bib35","doi-asserted-by":"crossref","first-page":"e1006573","DOI":"10.1371\/journal.ppat.1006573","article-title":"The gastric microbiome, its interaction with Helicobacter pylori, and its potential role in the progression to stomach cancer","volume":"13","author":"Noto","year":"2017","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.giec.2021.03.006_bib36","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1053\/j.gastro.2019.12.001","article-title":"AGA technical review on gastric intestinal metaplasia-natural history and clinical outcomes","volume":"158","author":"Gawron","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.giec.2021.03.006_bib37","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/dju116","article-title":"Effects of Helicobacter pylori treatment on gastric cancer incidence and mortality in subgroups","volume":"106","author":"Li","year":"2014","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.giec.2021.03.006_bib38","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1053\/j.gastro.2019.12.003","article-title":"AGA clinical practice guidelines on management of gastric intestinal metaplasia","volume":"158","author":"Gupta","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.giec.2021.03.006_bib39","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1055\/a-0859-1883","volume":"51","author":"Pimentel-Nunes","year":"2019","journal-title":"Endoscopy"},{"key":"10.1016\/j.giec.2021.03.006_bib40","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1136\/gutjnl-2018-318126","article-title":"British Society of Gastroenterology guidelines on the diagnosis and management of patients at risk of gastric adenocarcinoma","volume":"68","author":"Banks","year":"2019","journal-title":"Gut"},{"key":"10.1016\/j.giec.2021.03.006_bib41","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1136\/gutjnl-2015-309252","article-title":"Kyoto global consensus report on Helicobacter pylori gastritis","volume":"64","author":"Sugano","year":"2015","journal-title":"Gut"},{"key":"10.1016\/j.giec.2021.03.006_bib42","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/sj.bjc.6605380","article-title":"Family history and the risk of gastric cancer","volume":"102","author":"Yaghoobi","year":"2010","journal-title":"Br J Cancer"},{"key":"10.1016\/j.giec.2021.03.006_bib43","doi-asserted-by":"crossref","first-page":"e34","DOI":"10.1097\/MCG.0b013e3181a159c4","article-title":"Stomach cancer risk in gastric cancer relatives: interaction between Helicobacter pylori infection and family history of gastric cancer for the risk of stomach cancer","volume":"44","author":"Shin","year":"2010","journal-title":"J\u00a0Clin Gastroenterol"},{"key":"10.1016\/j.giec.2021.03.006_bib44","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1002\/ijc.10637","article-title":"Role of Helicobacter pylori infection among offspring or siblings of gastric cancer patients","volume":"101","author":"Chang","year":"2002","journal-title":"Int J Cancer"},{"key":"10.1016\/j.giec.2021.03.006_bib45","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1111\/j.1440-1746.2011.06717.x","article-title":"Helicobacter pylori infection and histological changes in siblings of young gastric cancer patients","volume":"26","author":"Nam","year":"2011","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.giec.2021.03.006_bib46","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0016-5085(00)70411-2","article-title":"Helicobacter pylori infection among offspring of patients with stomach cancer","volume":"118","author":"Brenner","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.giec.2021.03.006_bib47","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S0016-5085(00)70410-0","article-title":"Increased prevalence of precancerous changes in relatives of gastric cancer patients: critical role of H. pylori","volume":"118","author":"El-Omar","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.giec.2021.03.006_bib48","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1136\/gutjnl-2016-312288","article-title":"Management of Helicobacter pylori infection-the Maastricht V\/Florence Consensus Report","volume":"66","author":"Malfertheiner","year":"2017","journal-title":"Gut"},{"key":"10.1016\/j.giec.2021.03.006_bib49","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.cgh.2018.03.013","article-title":"Houston consensus conference on testing for Helicobacter pylori Infection in the United States","volume":"16","author":"El-Serag","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.giec.2021.03.006_bib50","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/ajg.2016.563","article-title":"ACG clinical guideline: treatment of Helicobacter pylori infection","volume":"112","author":"Chey","year":"2017","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.giec.2021.03.006_bib51","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/S0140-6736(08)61159-9","article-title":"Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial","volume":"372","author":"Fukase","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.giec.2021.03.006_bib52","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.cgh.2013.09.057","article-title":"Eradication of Helicobacter pylori after endoscopic resection of gastric tumors does not reduce incidence of metachronous gastric carcinoma","volume":"12","author":"Choi","year":"2014","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.giec.2021.03.006_bib53","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1586\/14737140.2014.911092","article-title":"Helicobacter pylori and the molecular pathogenesis of intestinal-type gastric carcinoma","volume":"14","author":"Hanada","year":"2014","journal-title":"Expert Rev Anticancer Ther"},{"key":"10.1016\/j.giec.2021.03.006_bib54","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1111\/j.1440-1746.2009.05982.x","article-title":"Second Asia-Pacific Consensus Guidelines for Helicobacter pylori infection","volume":"24","author":"Fock","year":"2009","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.giec.2021.03.006_bib55","first-page":"559","article-title":"Aspirin, ibuprofen, and other non-steroidal anti-inflammatory drugs in cancer prevention: a critical review of non-selective COX-2 blockade (review)","volume":"13","author":"Harris","year":"2005","journal-title":"Oncol Rep"},{"key":"10.1016\/j.giec.2021.03.006_bib56","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1093\/jnci\/djg106","article-title":"Non-steroidal anti-inflammatory drug use and the risk of gastric cancer: a systematic review and meta-analysis","volume":"95","author":"Wang","year":"2003","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.giec.2021.03.006_bib57","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0753-3322(00)88503-0","article-title":"Aspirin induced apoptosis in gastric cancer cells","volume":"53","author":"Wong","year":"1999","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.giec.2021.03.006_bib58","doi-asserted-by":"crossref","first-page":"6113","DOI":"10.1038\/sj.onc.1205778","article-title":"Novel target for induction of apoptosis by cyclo-oxygenase-2 inhibitor SC-236 through a protein kinase C-beta(1)-dependent pathway","volume":"21","author":"Jiang","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.giec.2021.03.006_bib59","doi-asserted-by":"crossref","first-page":"2952","DOI":"10.1200\/JCO.2009.26.0695","article-title":"Effective reduction of gastric cancer risk with regular use of nonsteroidal anti-inflammatory drugs in Helicobacter pylori-infected patients","volume":"28","author":"Wu","year":"2010","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.giec.2021.03.006_bib60","doi-asserted-by":"crossref","first-page":"27307","DOI":"10.1074\/jbc.274.38.27307","article-title":"Sulindac inhibits activation of the NF-kappaB pathway","volume":"274","author":"Yamamoto","year":"1999","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.giec.2021.03.006_bib61","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S1470-2045(09)70035-X","article-title":"Aspirin and non-steroidal anti-inflammatory drugs for cancer prevention: an international consensus statement","volume":"10","author":"Cuzick","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.giec.2021.03.006_bib62","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1093\/jnci\/djx267","article-title":"Aspirin and risk of gastric cancer after helicobacter pylori eradication: a territory-wide study","volume":"110","author":"Cheung","year":"2018","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.giec.2021.03.006_bib63","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1093\/aje\/kwp162","article-title":"Nonsteroidal antiinflammatory drugs and risk of gastric adenocarcinoma: the multiethnic cohort study","volume":"170","author":"Epplein","year":"2009","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.giec.2021.03.006_bib64","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1054\/bjoc.2001.1702","article-title":"Aspirin and risk for gastric cancer: a population-based case-control study in Sweden","volume":"84","author":"Akre","year":"2001","journal-title":"Br J Cancer"},{"key":"10.1016\/j.giec.2021.03.006_bib65","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/jgh3.12226","article-title":"Effect of aspirin use on gastric cancer incidence and survival: a systematic review and meta-analysis","volume":"4","author":"Niikura","year":"2020","journal-title":"JGH Open"},{"key":"10.1016\/j.giec.2021.03.006_bib66","doi-asserted-by":"crossref","first-page":"4781","DOI":"10.18632\/oncotarget.13591","article-title":"Aspirin and non-steroidal anti-inflammatory drugs use reduce gastric cancer risk: a dose-response meta-analysis","volume":"8","author":"Huang","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.giec.2021.03.006_bib67","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1136\/gut.34.6.748","article-title":"Effect of Helicobacter pylori colonisation on gastric mucosal eicosanoid synthesis in patients taking non-steroidal anti-inflammatory drugs","volume":"34","author":"Hudson","year":"1993","journal-title":"Gut"},{"issue":"Suppl 1","key":"10.1016\/j.giec.2021.03.006_bib68","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1046\/j.1365-2036.2000.014s1044.x","article-title":"The effect of NSAIDs and a COX-2 specific inhibitor on Helicobacter pylori-induced PGE2 and HGF in human gastric fibroblasts","volume":"14","author":"Takahashi","year":"2000","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.giec.2021.03.006_bib69","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1136\/gut.52.4.490","article-title":"Aspirin inhibits the growth of Helicobacter pylori and enhances its susceptibility to antimicrobial agents","volume":"52","author":"Wang","year":"2003","journal-title":"Gut"},{"key":"10.1016\/j.giec.2021.03.006_bib70","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/(SICI)1099-1263(199805\/06)18:3<179::AID-JAT494>3.0.CO;2-W","article-title":"Ibuprofen affects arylamine N-acetyltransferase activity in Helicobacter pylori from peptic ulcer patients","volume":"18","author":"Chang","year":"1998","journal-title":"J\u00a0Appl Toxicol"},{"key":"10.1016\/j.giec.2021.03.006_bib71","doi-asserted-by":"crossref","first-page":"8166","DOI":"10.1158\/0008-5472.CAN-08-3856","article-title":"Combination of sulindac and antimicrobial eradication of Helicobacter pylori prevents progression of gastric cancer in hypergastrinemic INS-GAS mice","volume":"69","author":"Lee","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.giec.2021.03.006_bib72","doi-asserted-by":"crossref","first-page":"4766","DOI":"10.1158\/1078-0432.CCR-06-0693","article-title":"Effects of long-term rofecoxib on gastric intestinal metaplasia: results of a randomized controlled trial","volume":"12","author":"Leung","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.giec.2021.03.006_bib73","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1001\/jama.294.1.47","article-title":"Low-Dose Aspirin in the Primary Prevention of Cancer","volume":"294","author":"Cook","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.giec.2021.03.006_bib74","unstructured":"Available at: whs.bwh.harvard.edu\/images\/WHS website-Overview of study.pdf. Accessed November 3, 2020."},{"key":"10.1016\/j.giec.2021.03.006_bib75","doi-asserted-by":"crossref","first-page":"E751","DOI":"10.1073\/pnas.1614958114","article-title":"Ornithine decarboxylase regulates M1 macrophage activation and mucosal inflammation via histone modifications","volume":"114","author":"Hardbower","year":"2017","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"key":"10.1016\/j.giec.2021.03.006_bib76","doi-asserted-by":"crossref","first-page":"3429","DOI":"10.1038\/onc.2014.273","article-title":"Increased Helicobacter pylori-associated gastric cancer risk in the Andean region of Colombia is mediated by spermine oxidase","volume":"34","author":"Chaturvedi","year":"2015","journal-title":"Oncogene"},{"key":"10.1016\/j.giec.2021.03.006_bib77","doi-asserted-by":"crossref","first-page":"5077","DOI":"10.1073\/pnas.1814497116","article-title":"\u03b1-Difluoromethylornithine reduces gastric carcinogenesis by causing mutations in Helicobacter pylori cagY","volume":"116","author":"Sierra","year":"2019","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"key":"10.1016\/j.giec.2021.03.006_bib78","doi-asserted-by":"crossref","first-page":"e17510","DOI":"10.1371\/journal.pone.0017510","article-title":"Difluoromethylornithine is a novel inhibitor of Helicobacter pylori growth, CagA translocation, and interleukin-8 induction","volume":"6","author":"Barry","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.giec.2021.03.006_bib79","first-page":"1739","article-title":"Role of obesity in a randomized placebo-controlled trial of difluoromethylornithine (DFMO)\u00a0+ sulindac for the prevention of sporadic colorectal adenomas","volume":"23","author":"Zell","year":"2012","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.giec.2021.03.006_bib80","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1053\/j.gastro.2010.06.005","article-title":"Levels of rectal mucosal polyamines and prostaglandin E2 predict ability of DFMO and sulindac to prevent colorectal adenoma","volume":"139","author":"Thompson","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.giec.2021.03.006_bib81","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/bjc.2013.15","article-title":"Role of dietary polyamines in a phase III clinical trial of difluoromethylornithine (DFMO) and sulindac for prevention of sporadic colorectal adenomas","volume":"108","author":"Raj","year":"2013","journal-title":"Br J Cancer"},{"key":"10.1016\/j.giec.2021.03.006_bib82","doi-asserted-by":"crossref","first-page":"l5016","DOI":"10.1136\/bmj.l5016","article-title":"Effects of Helicobacter pylori treatment and vitamin and garlic supplementation on gastric cancer incidence and mortality: follow-up of a randomized intervention trial","volume":"366","author":"Li","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.giec.2021.03.006_bib83","first-page":"39","article-title":"Effects of aged garlic extract (AGE) on colorectal adenomas: a double-blinded study","volume":"53","author":"Tanaka","year":"2004","journal-title":"Hiroshima J Med Sci"},{"key":"10.1016\/j.giec.2021.03.006_bib84","first-page":"1155","article-title":"An intervention study to prevent gastric cancer by micro-selenium and large dose of allitridum","volume":"117","author":"Li","year":"2004","journal-title":"Chin Med J"},{"key":"10.1016\/j.giec.2021.03.006_bib85","article-title":"Associations between calcium and magnesium intake and the risk of incident gastric cancer: a prospective cohort analysis of the National Institutes of Health-American Association of Retired Persons (NIH-AARP) Diet and Health Study","author":"Shah","year":"2019","journal-title":"Int J Cancer"},{"key":"10.1016\/j.giec.2021.03.006_bib86","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18081699","article-title":"Prevention of gastric cancer: eradication of helicobacter pylori and beyond","volume":"18","author":"Tsukamoto","year":"2017","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.giec.2021.03.006_bib87","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1080\/09637486.2016.1198892","article-title":"Inhibition of green tea polyphenol EGCG((-)-epigallocatechin-3-gallate) on the proliferation of gastric cancer cells by suppressing canonical wnt\/\u03b2-catenin signalling pathway","volume":"67","author":"Yang","year":"2016","journal-title":"Int J Food Sci Nutr"},{"key":"10.1016\/j.giec.2021.03.006_bib88","first-page":"310","article-title":"Green tea consumption and chronic atrophic gastritis: a cross-sectional study in a green tea production village","volume":"10","author":"Shibata","year":"2000","journal-title":"J\u00a0Epidemiol"},{"key":"10.1016\/j.giec.2021.03.006_bib89","first-page":"209","article-title":"Tea and coffee consumption and the risk of digestive tract cancers: data from a comparative case-referent study in Japan","volume":"9","author":"Inoue","year":"1998","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.giec.2021.03.006_bib90","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1158\/1055-9965.EPI-06-1009","article-title":"Ginseng intake and gastric cancer risk in the Shanghai Women\u2019s Health Study cohort","volume":"16","author":"Kamangar","year":"2007","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.giec.2021.03.006_bib91","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1053\/j.gastro.2009.12.004","article-title":"Selenium status and the risk of esophageal and gastric cancer subtypes: the Netherlands cohort study","volume":"138","author":"Steevens","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.giec.2021.03.006_bib92","first-page":"1423","article-title":"Metformin inhibits gastric cancer via the inhibition of HIF1\u03b1\/PKM2 signaling","volume":"5","author":"Chen","year":"2015","journal-title":"Am J Cancer Res"},{"key":"10.1016\/j.giec.2021.03.006_bib93","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1158\/1535-7163.MCT-11-0594","article-title":"The antidiabetic drug metformin inhibits gastric cancer cell proliferation in\u00a0vitro and in\u00a0vivo","volume":"11","author":"Kato","year":"2012","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.giec.2021.03.006_bib94","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ejca.2017.07.020","article-title":"Metformin targets gastric cancer stem cells","volume":"84","author":"Courtois","year":"2017","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.giec.2021.03.006_bib95","doi-asserted-by":"crossref","first-page":"12748","DOI":"10.18632\/oncotarget.3327","article-title":"Metformin potentiates rapamycin and cisplatin in gastric cancer in mice","volume":"6","author":"Yu","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.giec.2021.03.006_bib96","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1007\/s12094-020-02304-y","article-title":"The effect of metformin on gastric cancer in patients with type 2 diabetes: a systematic review and meta-analysis","volume":"22","author":"Shuai","year":"2020","journal-title":"Clin Transl Oncol"},{"key":"10.1016\/j.giec.2021.03.006_bib97","doi-asserted-by":"crossref","first-page":"8545","DOI":"10.2147\/CMAR.S264032","article-title":"Preventative and therapeutic effects of metformin in gastric cancer: a new contribution of an old friend","volume":"12","author":"Zhang","year":"2020","journal-title":"Cancer Manag Res"},{"key":"10.1016\/j.giec.2021.03.006_bib98","doi-asserted-by":"crossref","first-page":"55622","DOI":"10.18632\/oncotarget.16973","article-title":"Association between metformin and the risk of gastric cancer in patients with type 2 diabetes mellitus: a meta-analysis of cohort studies","volume":"8","author":"Zhou","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.giec.2021.03.006_bib99","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1093\/jnci\/djy144","article-title":"Metformin use and gastric cancer risk in diabetic patients after helicobacter pylori eradication","volume":"111","author":"Cheung","year":"2019","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.giec.2021.03.006_bib100","first-page":"823","article-title":"Metformin use and incidence cancer risk: evidence for a selective protective effect against liver cancer","volume":"29","author":"Murff","year":"2018","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.giec.2021.03.006_bib101","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1038\/s41416-019-0598-z","article-title":"Metformin use and risk of gastric adenocarcinoma in a Swedish population-based cohort study","volume":"121","author":"Zheng","year":"2019","journal-title":"Br J Cancer"},{"key":"10.1016\/j.giec.2021.03.006_bib102","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1093\/jnci\/djz066","article-title":"RE: metformin use and gastric cancer risk in diabetic patients after helicobacter pylori eradication","volume":"111","author":"Khosrow-Khavar","year":"2019","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.giec.2021.03.006_bib103","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1093\/jnci\/djz067","article-title":"Response to Khosrow-Khavar, Kurteva, and Douros","volume":"111","author":"Cheung","year":"2019","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.giec.2021.03.006_bib104","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1016\/j.ejca.2008.06.025","article-title":"Statins and cancer: a systematic review and meta-analysis","volume":"44","author":"Kuoppala","year":"2008","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.giec.2021.03.006_bib105","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1002\/ijc.22366","article-title":"Statins and risk of cancer: a systematic review and metaanalysis","volume":"120","author":"Browning","year":"2007","journal-title":"Int J Cancer"},{"key":"10.1016\/j.giec.2021.03.006_bib106","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1093\/jnci\/93.7.559-a","article-title":"RESPONSE: Re: chemoprevention of gastric dysplasia: randomized trial of antioxidant supplements and anti-Helicobacter pylori therapy","volume":"93","author":"Correa","year":"2001","journal-title":"JNCI J Natl Cancer Inst"},{"key":"10.1016\/j.giec.2021.03.006_bib107","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1136\/gutjnl-2016-311685","article-title":"Dynamics of Helicobacter pylori infection as a determinant of progression of gastric precancerous lesions: 16-year follow-up of an eradication trial","volume":"67","author":"Mera","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.giec.2021.03.006_bib108","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.3760\/cma.j.issn.0366-6999.20132494","article-title":"Relationship of Helicobacter pylori eradication with gastric cancer and gastric mucosal histological changes: a 10-year follow-up study","volume":"127","author":"Zhou","year":"2014","journal-title":"Chin Med J"}],"container-title":["Gastrointestinal Endoscopy Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1052515721000295?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1052515721000295?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T07:21:53Z","timestamp":1760944913000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1052515721000295"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":108,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["S1052515721000295"],"URL":"https:\/\/doi.org\/10.1016\/j.giec.2021.03.006","relation":{},"ISSN":["1052-5157"],"issn-type":[{"value":"1052-5157","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chemoprevention Against Gastric Cancer","name":"articletitle","label":"Article Title"},{"value":"Gastrointestinal Endoscopy Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.giec.2021.03.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}